Sign In
Buy ARIA
$23.99
+0 (+0%)
At Close: Mar 13, 2017
Modified Titration of Donanemab Demonstrated Reduction of ARIA-E in Early Symptomatic Alzheimer's Disease Patients in Phase 3b study
12:15pm, Tuesday, 29'th Oct 2024
A change in the initiation of donanemab dosing, shifting one vial of donanemab from the first infusion to the third infusion, lowered ARIA-E to 14% compared to 24% in patients receiving the standard d
WEST PALM BEACH, Fla. , Oct. 24, 2024 /PRNewswire/ -- Ethema Health Corporation's (OTCPINK: GRST) ("Ethema" "GRST" or the "Company"), wholly owned subsidiary ARIA, received its full license to opera
ARIA Cybersecurity to Highlight Impact of Industrial Cybersecurity Attacks at Rockwell Automation Fair
08:00am, Friday, 26'th Jul 2024
ARIA Cybersecurity asked to update the industry on cybersecurity risk measurement and attack defense strategies BOSTON, MA / ACCESSWIRE / July 26, 2024 / ARIA Cybersecurity Solutions, a CSPi business
ARIA AZT PROTECT Combined with the Forescout Platform Delivers Enhanced OT Critical Application Visibility and Protection LOWELL, MA / ACCESSWIRE / June 27, 2024 / ARIA Cybersecurity Solutions, a CSP
TOKYO and CAMBRIDGE, Mass. , Aug. 3, 2022 /PRNewswire/ -- Eisai Co., Ltd.
ARIAD Enters into Definitive Agreement to Be Acquired by Takeda for $5.2 Billion
08:02am, Monday, 09'th Jan 2017
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals (NASDAQ:ARIA) (“ARIAD”) today announced it has entered into a definitive agreement to be acquired by Takeda Pharmaceutical Company Limited
ARIAD to Host Webcast and Conference Call on Brigatinib Data Presentations at the World Conference on Lung Cancer
04:05pm, Friday, 02'nd Dec 2016
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA), a rare cancer-focused innovative biotechnology company, today announced a conference call and webcast to discuss the clini
ARIAD to Webcast Conference Call on Third Quarter 2016 Financial Results
07:35am, Tuesday, 01'st Nov 2016
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its third quarter 2016 financial results on Monday, November 7, 2016, before the marke
ARIAD Reports Second Quarter and First Half 2016 Financial Results
07:35am, Thursday, 28'th Jul 2016
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the second quarter and first half of 2016, including revenue from sales of Iclusig®
ARIAD to Webcast Conference Call on Second Quarter 2016 Financial Results
07:35am, Tuesday, 05'th Jul 2016
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its second quarter 2016 financial results on Thursday, July 28, 2016, before the marke
ARIAD Reports First Quarter 2016 Financial Results and Progress on Strategic Review
07:35am, Tuesday, 10'th May 2016
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the first quarter of 2016, including revenue from sales of Iclusig® (ponatinib). The
ARIAD to Webcast Conference Call on First Quarter 2016 Financial Results
07:35am, Tuesday, 26'th Apr 2016
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its first quarter 2016 financial results on Tuesday, May 10, 2016, before the market o
ARIAD Reports 2015 Financial Results, Provides 2016 Product Revenue Guidance and Outlines Company Progress
07:35am, Tuesday, 23'rd Feb 2016
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the fourth quarter and full year ended December 31, 2015 and issued 2016 product reve
ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2015 Financial Results
07:35am, Tuesday, 02'nd Feb 2016
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its fourth quarter and year-end 2015 financial results on Tuesday, February 23, 2016,
ARIAD to Webcast Conference Call on Third Quarter 2015 Financial Results
07:35am, Tuesday, 27'th Oct 2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its third quarter 2015 financial results on Tuesday, November 3, 2015, before the mark
